Pinnacle Bancorp’s Core Laboratories CLB Stock Holding History

Pinnacle Bancorp’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$17K	Buy	+146	New	+$17K	0.01%	432

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Pinnacle Bancorp's CLB Position: Q1 2017 in Review

Pinnacle Bancorp opened a new position in Core Laboratories (CLB) in Q1 2017: 146 shares worth $17K. The stake represents 0.01% of the portfolio and ranks #432 among its holdings.

360 funds tracked by Wall St. Rank hold CLB as of Q1 2017.

Pinnacle Bancorp held 146 shares of Core Laboratories worth $17K as of Q1 2017.
Core Laboratories was a new Pinnacle Bancorp position in Q1 2017.
Core Laboratories made up 0.01% of Pinnacle Bancorp's portfolio in Q1 2017, its #432 holding.
360 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2017.

Based on Pinnacle Bancorp's 13F filing for Q1 2017, filed 17 Apr 2017.